Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

A phase Ib/II study of ivosidenib with venetoclax plus /- azacitidine in IDH1-mutated myeloid malignancies.

Lachowiez CA. et al, (2021), JOURNAL OF CLINICAL ONCOLOGY, 39

Oncogenic Gata1 causes stage-specific megakaryocyte differentiation delay.

Juban G. et al, (2021), Haematologica, 106, 1106 - 1119

Mechanisms of response and resistance to AML therapies

Stoilova B. et al, (2020), Clinical Lymphoma, Myeloma & Leukemia, 20, S7 - S7

Phase Ib/II study of the IDH1-mutant inhibitor ivosidenib with the BCL2 inhibitor venetoclax plus /- azacitidine in IDH1-mutated hematologic malignancies.

Lachowiez CA. et al, (2020), JOURNAL OF CLINICAL ONCOLOGY, 38

C/EBPalpha and GATA-2 mutations induce bi-lineage acute erythroid leukemia through transformation of a neomorphic neutrophil-erythroid progenitor

NERLOV C. et al, (2020), Cancer Cell

OncogenicGata1causes stage-specific megakaryocyte differentiation delay

Juban G. et al, (2019), Haematologica: the hematology journal

Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome.

Labuhn M. et al, (2019), Cancer cell, 36, 340 - 340

The Inflammasome: More Than a Protective Innate Immune Mechanism

(2019), Immunity

Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome.

Labuhn M. et al, (2019), Cancer Cell, 36, 123 - 138.e10

A Recurrent Activating Missense Mutation in Waldenström Macroglobulinemia Affects the DNA Binding of the ETS Transcription Factor SPI1 and Enhances Proliferation.

Roos-Weil D. et al, (2019), Cancer Discov, 9, 796 - 811

Clonal Heterogeneity of Acute Myeloid Leukemia Treated with the IDH2 inhibitor Enasidenib

Vyas P. et al, (2018), Nature Medicine

Single-cell analysis reveals the continuum of human lympho-myeloid progenitor cells.

Karamitros D. et al, (2018), Nat Immunol, 19, 85 - 97

A Novel Model of Human Hemopoiesis Based on Single Cell Functional and Transcriptional Analysis of Lympho-Myeloid Progenitors

Stoilova B. et al, (2017), BLOOD, 130

Clonal Heterogeneity in Differentiation Response and Resistance to the IDH2 Inhibitor Enasidenib in Acute Myeloid Leukemia

Quek L. et al, (2017), BLOOD, 130

Impact of Mutant Haemopoietic Transcription Factor GATA1s on Haemopoiesis

Vyas P. et al, (2017), BLOOD, 130

SINGLE CELL ASSAYS UNVEIL FUNCTIONAL AND TRANSCRIPTIONAL HETEROGENEITY OF HUMAN HEMOPOIETIC LYMPHO-MYELOID PROGENITORS

Stoilova B. et al, (2017), Experimental Hematology, 53

A NOVEL MODEL OF HUMAN LYMPHO-MYELOID PROGENITOR HIERARCHY BASED ON SINGLE CELL FUNCTIONAL AND TRANSCRIPTIONAL ANALYSIS

Karamitros D. et al, (2017), HAEMATOLOGICA, 102, 20 - 20

Genetically distinct leukemic stem cells in human CD34- acute myeloid leukemia are arrested at a hemopoietic precursor-like stage.

Quek L. et al, (2016), The Journal of experimental medicine, 213, 1513 - 1535

Lymphoid to myeloid cell trans-differentiation is determined by C/EBPβ structure and post-translational modifications.

Stoilova B. et al, (2013), PLoS One, 8

B cell to myeloid reprogramming by the transcription factor C/EBPβ.

Stoilova B. et al, (2010), J Stem Cells Regen Med, 6

Include forthcoming?